Latvia vs Morocco: Cause of death, by non-communicable diseases, ages 60+, female
Latvia
84.1%
in 2021
Morocco
83.7%
in 2021
Latvia rank
32nd
Morocco rank
35th
Cause of death, by non-communicable diseases, ages 60+, female over time
- Latvia
- Morocco
How they compare
Latvia currently reports 84.1% against 83.7% in Morocco, a difference of 0.4%.
Across all 6 years both countries report, Latvia has been ahead every year.
Latvia ranks 32nd and Morocco ranks 35th of 185 countries.
Latvia has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Latvia | Morocco | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 95.7% | 94.0% | 1.7% | Latvia |
| 2010s | 96.7% | 94.7% | 2.0% | Latvia |
| 2020s | 89.2% | 84.0% | 5.3% | Latvia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, ages 60+, female, Latvia or Morocco?
- Latvia, at 84.1% against 83.7% in Morocco as of 2021.
- What is the difference in cause of death, by non-communicable diseases, ages 60+, female between Latvia and Morocco?
- 0.4%, with Latvia ahead.
- How many years of comparable data are there for Latvia and Morocco?
- 6 years are reported by both, from 2000 to 2021.
- How do Latvia and Morocco rank globally for cause of death, by non-communicable diseases, ages 60+, female?
- Latvia ranks 32nd and Morocco ranks 35th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, ages 60+, female (% of total female deaths ages 60+). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths ages 60+ due to non-communicable diseases divided by number of all female deaths ages 60+, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.